Editorial introductions
How should clinicians address intratumour heterogeneity in clear cell renal cell carcinoma?
Current and future strategies in nonclear-cell metastatic renal cell carcinoma
The role of cytoreductive surgery in the era of targeted agents
Role of metastasectomy in metastatic renal cell carcinoma
Is observation a valid strategy in metastatic renal cell carcinoma?
First-line treatment of metastatic renal cell carcinoma after COMPARZ and PISCES
The role of rechallenge with targeted therapies in metastatic renal-cell carcinoma
T-cell checkpoint inhibitors in metastatic renal cell carcinoma
A precision, personalized approach to the management of bladder cancer
Sex difference in presentation and outcomes of bladder cancer
Prognostic significance of substage and WHO classification systems in T1 urothelial carcinoma of the bladder
Urinary diversion
Imaging muscle-invasive and metastatic urothelial carcinoma
Genetic subtypes of invasive bladder cancer
Management of muscle-invasive bladder cancer in the elderly
Managing noninvasive recurrences after definitive treatment for muscle-invasive bladder cancer or high-grade upper tract urothelial carcinoma
Trimodal therapy for invasive bladder cancer